John Hancock Life & Health Insurance Co Form 4 Filed 2024-01-04

FORM 4

☐	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0287
Expires:	02/28/2011
Estimated average burden
hours per response		0.5

1. Name and Address of Reporting Person ^*

John Hancock Life & Health Insurance Co

2. Issuer Name and Ticker or Trading Symbol
Manulife Private Credit Plus Fund [N/A]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

197 CLARENDON STREET

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2024

(Street)

BOSTON, MA 02116

(City)

(State)

(Zip)

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check applicable line)

__X__ Form Filed by One Reporting Person
_____ Form Filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	01/02/2024		P		197,531⁽¹⁾	A	$20.25⁽¹⁾	793,827⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Explanation of Responses:

1.	This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing.

	Signatures
	Betsy Anne Seel, by Power of Attorney	01/04/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY FOR JOHN HANCOCK LIFE & HEALTH INSURANCE COMPANY SECTION 16(a) FILINGS The undersigned, a duly authorized officer of John Hancock Life & Health Insurance Company, hereby constitutes and appoints with full power of substitution each of Sarah Coutu, Thomas Dee, Khimmara Greer, Kinga Kapuscinski, Suzanne Lambert, Nicholas J. Kolokithas, Edward Macdonald, Mara Moldwin, Harsha Pulluru, Christopher Sechler, Betsy Anne Seel and Steven Sunnerberg, acting singly, the undersigned's true and lawful attorney-in-fact to: (1) Prepare and execute for the undersigned Forms 3, 4, and 5 and amendments thereto regarding the John Hancock Life Insurance Company (U.S.A.)'s share ownership in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) File any such Form 3, 4, or 5 or amendments thereto with the United States Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority; and (3) Take any other action which, in the opinion of such attorney-in-fact, may be necessary or desirable in connection with the foregoing. The undersigned acknowledges that neither the foregoing attorneys-in-fact nor John Hancock Life & Health Insurance Company are assuming the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 and the rules thereunder. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney may be filed with the SEC as may be necessary or appropriate. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 23/rd/ day of August 2023. John Hancock Life & Health Insurance Company /s/ Tracy Lannigan ----------------------------------------------- Tracy Lannigan Assistant Chief Counsel and Corporate Secretary